Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES STRIDES PHARMA SCIENCE ZYDUS LIFESCIENCES/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 34.5 -1,432.1 - View Chart
P/BV x 5.8 3.2 180.4% View Chart
Dividend Yield % 0.6 0.2 303.9%  

Financials

 ZYDUS LIFESCIENCES   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
STRIDES PHARMA SCIENCE
Mar-23
ZYDUS LIFESCIENCES/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs495392 126.2%   
Low Rs319263 121.2%   
Sales per share (Unadj.) Rs170.3408.5 41.7%  
Earnings per share (Unadj.) Rs19.8-25.6 -77.3%  
Cash flow per share (Unadj.) Rs26.91.4 1,967.7%  
Dividends per share (Unadj.) Rs6.001.50 400.0%  
Avg Dividend yield %1.50.5 322.0%  
Book value per share (Unadj.) Rs173.0242.8 71.3%  
Shares outstanding (eoy) m1,012.2090.30 1,120.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.40.8 297.9%   
Avg P/E ratio x20.6-12.8 -160.6%  
P/CF ratio (eoy) x15.1239.6 6.3%  
Price / Book Value ratio x2.41.4 174.3%  
Dividend payout %30.3-5.9 -517.1%   
Avg Mkt Cap Rs m412,14429,603 1,392.2%   
No. of employees `000NANA-   
Total wages/salary Rs m24,5647,320 335.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,37436,884 467.3%  
Other income Rs m4,7461,352 351.0%   
Total revenues Rs m177,12038,236 463.2%   
Gross profit Rs m29,677830 3,576.5%  
Depreciation Rs m7,2272,433 297.1%   
Interest Rs m1,2992,611 49.7%   
Profit before tax Rs m25,897-2,862 -904.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,878-553 -1,062.9%   
Profit after tax Rs m20,019-2,309 -867.0%  
Gross profit margin %17.22.2 765.3%  
Effective tax rate %22.719.3 117.5%   
Net profit margin %11.6-6.3 -185.5%  
BALANCE SHEET DATA
Current assets Rs m100,08231,353 319.2%   
Current liabilities Rs m55,26729,902 184.8%   
Net working cap to sales %26.03.9 661.1%  
Current ratio x1.81.0 172.7%  
Inventory Days Days5071 70.7%  
Debtors Days Days94129 72.7%  
Net fixed assets Rs m144,77631,300 462.5%   
Share capital Rs m1,012903 112.1%   
"Free" reserves Rs m174,14621,025 828.3%   
Net worth Rs m175,15821,928 798.8%   
Long term debt Rs m011,398 0.0%   
Total assets Rs m244,94063,734 384.3%  
Interest coverage x20.9-0.1 -21,818.6%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.70.6 121.6%   
Return on assets %8.70.5 1,834.1%  
Return on equity %11.4-10.5 -108.5%  
Return on capital %15.5-0.8 -2,065.0%  
Exports to sales %39.246.7 84.0%   
Imports to sales %11.90-   
Exports (fob) Rs m67,57717,213 392.6%   
Imports (cif) Rs m20,544NA-   
Fx inflow Rs m67,57718,113 373.1%   
Fx outflow Rs m20,544672 3,059.3%   
Net fx Rs m47,03317,442 269.7%   
CASH FLOW
From Operations Rs m26,888444 6,054.4%  
From Investments Rs m11,7123,025 387.2%  
From Financial Activity Rs m-44,004-2,139 2,057.0%  
Net Cashflow Rs m-5,3381,328 -402.0%  

Share Holding

Indian Promoters % 75.0 27.4 273.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.0 38.9 46.4%  
FIIs % 5.0 19.5 25.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 72.6 34.5%  
Shareholders   306,495 91,182 336.1%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs STRIDES PHARMA SCIENCE Share Price Performance

Period Cadila Healthcare STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day 1.42% -0.45% 1.18%
1-Month 8.68% -1.26% -0.75%
1-Year 109.28% 172.46% 61.82%
3-Year CAGR 32.67% -3.87% 18.16%
5-Year CAGR 24.73% 10.62% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.